ALT5 Sigma Corporation (ALTS)

Over the past six months, ALT5 Sigma Corp.'s stock price has experienced significant volatility and a notable decline. In January 2026, the company announced a stock buyback program, joined the World Liberty Forum, launched ALT5 AI, restored Nasdaq compliance, reported Q3 2025 financial results, and reported a record annual transaction volume. In December 2025, Jane Street Group, LLC significantly reduced its stake in ALT5 Sigma Corp. In November 2025, the company was notified of non-compliance with filing requirements, which was later resolved, and its infrastructure was included in a joint venture. In September 2025, the stock was priced at $3.925, with analysts forecasting a target price of $24.00. In March 2025, ALT5 Sigma reported strong Q4 and full-year 2024 results, and Ron Pitters was appointed as the new Chief Operating Officer.

There is no direct information available regarding the seasonality of demand for ALT5 Sigma Corp.'s specific products and services, but historical stock performance data suggests some seasonality in its stock returns. August has shown the highest probability of positive returns, whereas September has the lowest probability.

ALT5 Sigma Corp. is a multidisciplinary organization in the fintech and biotechnology sectors, headquartered in Las Vegas, Nevada. The company focuses on blockchain-powered technologies for digital asset management and develops non-opioid therapies for pain and addiction. The Fintech segment provides blockchain-powered technologies for digital asset management, including ALT 5 Prime, ALT 5 Pay, and modular technology solutions. The Biotechnology segment focuses on developing non-opioid therapies, including JAN 101 and JAN123. The company is categorized in the Technology sector, with a focus on Software - Application, and has a presence in the Financials sector.

ALT5 Sigma Corp. provides blockchain-powered technologies worldwide. The company is based in Las Vegas, Nevada, and maintains global operations with offices in New York, London, and Hong Kong. It is registered with FinCEN, FINTRAC (Canada), and the Lithuania Central Bank.

ALT5 Sigma Corp.'s brand reputation presents a mixed picture. One analyst has given a "Strong Buy" rating, while another has issued a "Sell" rating, resulting in a consensus rating of "Sell". The company's MarketRank™ score is low. However, the company has received positive feedback from customers. Positive events include regaining Nasdaq compliance, board approval for a stock buyback program, strategic token acquisition initiatives, the launch of ALT5 AI, and reporting record annual transaction volume. Negative events include the significant decline in stock price and the reduction in stake by Jane Street Group.

ALT5 Sigma Corporation has a diverse ownership structure. Institutional investors hold approximately 9.72% to 34.41% of the company's stock, while insiders own about 0.05% to 4.64%. Public companies and retail investors hold a significant portion, ranging from 60.95% to 90.24%. Major institutional owners include Jane Street Group, Llc, Vanguard Group Inc, Diametric Capital, LP, ExodusPoint Capital Management, LP, Susquehanna International Group, Llp, Crcm Lp, Prelude Capital Management, Llc, UBS Group AG, Nwi Management Lp, Alyeska Investment Group, L.P., and Blackrock Inc. Zachary S. Folkman is the largest individual shareholder.